5 Key Takeaways

• 1

  AI has the potential to revolutionize rare disease drug discovery by analyzing vast datasets and identifying patterns.

• 2

  Data scarcity and fragmentation hinder rare disease treatment innovation, making comprehensive analysis challenging.

• 3

  AI can improve early diagnosis of rare diseases by distinguishing symptoms from more common conditions.

• 4

  The average cost of developing a rare disease drug is between $1 billion and $2 billion, despite regulatory incentives.

• 5

  Smaller biotech companies are primarily responsible for rare disease drug research and development due to financial burdens.